L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions

被引:35
|
作者
Pfeifer, Marco [1 ]
Schirmer, Uwe [1 ]
Geismann, Claudia [2 ]
Schaefer, Heiner [2 ]
Sebens, Susanne [2 ]
Altevogt, Peter [1 ]
机构
[1] German Canc Res Ctr, Dept Translat Immunol, D-69120 Heidelberg, Germany
[2] Univ Kiel, Clin Internal Med 1, Lab Mol Gastroenterol & Hepatol, D-21405 Kiel, Germany
来源
BMC MOLECULAR BIOLOGY | 2010年 / 11卷
关键词
CELL-ADHESION MOLECULE; E-CADHERIN EXPRESSION; BETA-CATENIN; GENE-EXPRESSION; UP-REGULATION; L1; SLUG; GROWTH; CANCER; L1-CAM;
D O I
10.1186/1471-2199-11-64
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The L1 cell adhesion molecule (L1CAM) was originally identified as a neural adhesion molecule involved in axon guidance. In many human epithelial carcinomas L1CAM is overexpressed and thereby augments cell motility, invasion and metastasis formation. L1CAM positive carcinomas are associated with bad prognosis. Recent data point out that L1CAM is regulated in a fashion similar to epithelial- mesenchymal transition (EMT). Previous studies have implied the transcription factors Slug and/or beta-catenin in L1CAM transcriptional regulation. However, the regulation of human L1CAM expression at the transcriptional level is not well understood. Results: To better understand the molecular basis of L1CAM transcriptional regulation, we carried out a detailed characterization of the human L1CAM promoter. We identified two transcription start sites, the first in front of a non-translated exon 0 (promoter 1) and the other next to the first protein-coding exon 1 (promoter 2). Both sites could be verified in endometrial carcinoma (EC) cell lines and appear to be used in a cell-type specific manner. The two identified promoter regions showed activity in luciferase reporter assays. Chromatin-IP analyses confirmed the in silico predicted E-boxes, binding sites for transcription factors Snail and Slug, as well as Lef-1 sites, which are related to beta-catenin-mediated transcriptional regulation, in both promoters. Overexpression of beta-catenin exclusively augmented activity of promoter 1 whereas Slug enhanced promoter 1 and 2 activity suggesting that both promoters can be active. Overexpression of beta-catenin or Slug could upregulate L1CAM expression in a cell-type specific manner. Conclusions: Our results, for the first time, provide evidence that the L1CAM gene has two functionally active promoter sites that are used in a cell-type specific manner. Slug and beta-catenin are involved L1CAM transcriptional regulation. Nevertheless, Slug rather than beta-catenin levels are correlated with L1CAM expression in EC cell lines. Our findings suggest that the L1CAM transcriptional regulation is more complex than anticipated and this study provides the basis for a better understanding of L1CAM regulation in non-neuronal/tumor cells.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
    van der Putten, Louis J. M.
    Visser, Nicole C. M.
    van de Vijver, Koen
    Santacana, Maria
    Bronsert, Peter
    Bulten, Johan
    Hirschfeld, Marc
    Colas, Eva
    Gil-Moreno, Antonio
    Garcia, Angel
    Mancebo, Gemma
    Alameda, Fransesc
    Trovik, Jone
    Kopperud, Reidun K.
    Huvila, Jutta
    Schrauwen, Stefanie
    Koskas, Martin
    Walker, Francine
    Weinberger, Vit
    Minar, Lubos
    Jandakova, Eva
    Snijders, Marc P. L. M.
    van den Berg-van Erp, Saskia
    Matias-Guiu, Xavier
    Salvesen, Helga B.
    Amant, Frederic
    Massuger, Leon F. A. G.
    Pijnenborg, Johanna M. A.
    BRITISH JOURNAL OF CANCER, 2016, 115 (06) : 716 - 724
  • [2] L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma
    Romani, Chiara
    Capoferri, Davide
    Reijnen, Casper
    Lonardi, Silvia
    Ravaggi, Antonella
    Ratti, Martina
    Bugatti, Mattia
    Zanotti, Laura
    Tognon, Germana
    Sartori, Enrico
    Odicino, Franco
    Calza, Stefano
    Pijnenborg, Johanna M. A.
    Bignotti, Eliana
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (04) : 637 - 648
  • [3] L1CAM malfunction in the nervous system and human carcinomas
    Schaefer, Michael K. E.
    Altevogt, Peter
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (14) : 2425 - 2437
  • [4] L1CAM malfunction in the nervous system and human carcinomas
    Michael K. E. Schäfer
    Peter Altevogt
    Cellular and Molecular Life Sciences, 2010, 67 : 2425 - 2437
  • [5] L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile
    Kommoss, Felix K. F.
    Karnezis, Anthony N.
    Kommoss, Friedrich
    Talhouk, Aline
    Taran, Florin-Andrei
    Staebler, Annette
    Gilks, C. Blake
    Huntsman, David G.
    Kraemer, Bernhard
    Brucker, Sara Y.
    McAlpine, Jessica N.
    Kommoss, Stefan
    BRITISH JOURNAL OF CANCER, 2018, 119 (04) : 480 - 486
  • [6] Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer
    Van Gool, Inge C.
    Stelloo, Ellen
    Nout, Remi A.
    Nijman, Hans W.
    Edmondson, Richard J.
    Church, David N.
    MacKay, Helen J.
    Leary, Alexandra
    Powell, Melanie E.
    Mileshkin, Linda
    Creutzberg, Carien L.
    Smit, Vincent T. H. B. M.
    Bosse, Tjalling
    MODERN PATHOLOGY, 2016, 29 (02) : 174 - 181
  • [7] Evaluating L1CAM expression in human endometrial cancer using qRT-PCR
    Notaro, Sara
    Reimer, Daniel
    Duggan-Peer, Michaela
    Fiegl, Heidi
    Wiedermair, Annamarie
    Roessler, Julia
    Altevogt, Peter
    Marth, Christian
    Zeimet, Alain Gustave
    ONCOTARGET, 2016, 7 (26) : 40221 - 40232
  • [8] Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients
    Tangen, Ingvild L.
    Kopperud, Reidun K.
    Visser, Nicole C. M.
    Staff, Anne C.
    Tingulstad, Solveig
    Marcickiewicz, Janusz
    Amant, Frederc
    Bjorge, Line
    Pijnenborg, Johanna M. A.
    Salvesen, Helga B.
    Werner, Henrica M. J.
    Trovik, Jone
    Krakstad, Camilla
    BRITISH JOURNAL OF CANCER, 2017, 117 (06) : 840 - 847
  • [9] Preoperative Risk Stratification of Endometrial Carcinoma: L1CAM as a Biomarker
    Pasanen, Annukka
    Loukovaara, Mikko
    Tuomi, Taru
    Butzow, Ralf
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (07) : 1318 - 1324
  • [10] L1CAM is not a reliable predictor for lymph node metastases in endometrial cancer, but L1CAM positive patients benefit from radiotherapy
    Zeiter, Deborah
    Vlajnic, Tatjana
    Schoetzau, Andreas
    Heinzelmann-Schwarz, Viola
    Montavon, Celine
    JOURNAL OF CANCER, 2021, 12 (21): : 6401 - 6410